Advertisement

Topics

Lannett Sees Profit Dive But Retains ‘Positive’ Outlook

01:49 EDT 13 May 2019 | SCRIP

US firm Lannett, which recently lost a key distribution deal involving a highly profitable thyroid drug, raised its sales guidance...

      

Related Stories

 

Original Article: Lannett Sees Profit Dive But Retains ‘Positive’ Outlook

NEXT ARTICLE

More From BioPortfolio on "Lannett Sees Profit Dive But Retains ‘Positive’ Outlook"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Thyroid Disorders
The thyroid is a butterfly-shaped gland in the neck, just above thecollarbone and is an endocrine gland that make hormones. These Thyroid hormones control the rate of many activities in the body, including how fast the body burns calories and how fast th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...